Covid-19 vaccine candidate 94.5 percent effective, Moderna says

01:54

Biotech company Moderna said on Monday that early analysis from its phase 3 trial shows its Covid-19 vaccine is 94.5 percent effective at preventing the infection, offering hope of a second breakthrough in as many weeks.